SCHEMBL25516147

SCHEMBL25516147

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5nc6c7ccccc7nc(-c7ccccc7)n6n5)cc4)cc3)n2)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 9/20 0.88
ADORA1 P30542 2/20 0.88
PDPK1 O15530 1/20 0.62
MEN1 O00255 1/20 0.54
GAA P10253 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 1/20 0.54
MAPT P10636 4/20 0.53
POLB P06746 1/20 0.50
TP53 P04637 1/20 0.49
ADORA2A P29274 2/20 0.49
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25516153 0.92 ADORA3 (0.74) ADORA3ADORA1PDPK1MEN1GAA
SCHEMBL24840151 0.92 ADORA3 (0.74) ADORA3ADORA1PDPK1MEN1GAA
SCHEMBL24840150 0.90 ADORA3 (0.81) ADORA3ADORA1PDPK1MEN1GAA
SCHEMBL24840156 0.81 ADORA3 (0.58) ADORA3ADORA1PDPK1MEN1GAA
SCHEMBL24840155 0.79 ADORA3 (0.59) ADORA3ADORA1PDPK1MEN1GAA
SCHEMBL29646414 0.77 ADORA3 (0.69) ADORA3ADORA1MEN1GAAHTT
SCHEMBL22979023 0.77 ADORA3 (0.69) ADORA3ADORA1MEN1GAAHTT
SCHEMBL25685721 0.77 ALDH1A1 (0.54) ADORA3ADORA1PDPK1MEN1KMT2A
SCHEMBL22979475 0.74 ADORA3 (0.64) ADORA3ADORA1HTTMAPTPOLB
SCHEMBL29646504 0.74 ADORA3 (0.64) ADORA3ADORA1HTTMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200219-A1 A compound, an organic electroluminescent device and a display device BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) 2023-06-22 US disclosed
US-20230200219-A1 A compound, an organic electroluminescent device and a display device BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) 2023-06-22 US disclosed
WO-2023093094-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS 昆山国显光电有限公司 2023-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200219-A1 A compound, an organic electroluminescent device and a display device L1CAM, VDAC2, CD274 ADORA3 682/4885ADORA1 246/4885PDPK1 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.